Drug-Coated Balloon Versus Standard Balloon for Superficial Femoral Artery In-Stent Restenosis: The Randomized Femoral Artery In-Stent Restenosis (FAIR) Trial Running title: Krankenberg et al.; DCBA versus POBA for SFA in-stent restenosis
نویسندگان
چکیده
Dept of Angiology, Cardiovascular Center (HGZ) Bad Bevensen, Bad Bevensen, Germany; Medtronic, Meerbusch, Germany; Asklepios proresearch, Hamburg, Germany; University of Leipzig Heart Center, Leipzig, Germany; Dept of Internal Medicine, SHR Clinic KarlsbadLangensteinbach, Karlsbad-Langensteinbach, Germany; Hamburg University Cardiovascular Center, Hamburg, Germany; Dept of Angiology, University Medical Center HamburgEppendorf, Hamburg, Germany; Dept of Angiology, Heart Center Bad Krozingen, Bad Krozingen, Germany *shared first authorship
منابع مشابه
Drug-Coated Balloon Versus Standard Balloon for Superficial Femoral Artery In-Stent Restenosis: The Randomized Femoral Artery In-Stent Restenosis (FAIR) Trial.
BACKGROUND Drug-coated balloon angioplasty (DCBA) was shown to be superior to standard balloon angioplasty (POBA) in terms of restenosis prevention for de novo superficial femoral artery disease. For in-stent restenosis, the benefit of DCBA over POBA remains uncertain. METHODS AND RESULTS One hundred nineteen patients with superficial femoral artery in-stent restenosis and chronic limb ischem...
متن کاملISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial
BACKGROUND Paclitaxel-eluting balloon (PEB) angioplasty has superior efficacy compared with conventional balloon angioplasty (BA) for de novo lesions of superficial femoral artery (SFA). Studies investigating the angiographic and clinical performance of PEB angioplasty versus BA for in-stent restenosis of SFA are limited. We performed a randomized trial to investigate angiographic and clinical ...
متن کاملDrug-Coated Balloons for Long Superficial Femoral Artery Disease: Leaving Nothing Behind in the Real-World.
SEE PAGE 950 T he optimal endovascular strategy for treatment of superficial femoral artery (SFA) atherosclerotic disease is an evolving area of research and clinical practice. Initial randomized trials demonstrated a benefit of nitinol self-expanding stent placement in this region when compared to standalone balloon angioplasty (1). However, observational studies subsequently raised concerns r...
متن کاملSustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional Stenting
Background—Primary stenting with self-expanding nitinol stents of the superficial femoral artery yielded improved morphological and clinical results compared with balloon angioplasty with optional stenting until 12 months in a randomized controlled trial. We now report 2-year data on restenosis and clinical outcomes of these patients. Methods and Results—Of 104 patients with chronic limb ischem...
متن کاملCommentary. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting.
BACKGROUND Primary stenting with self-expanding nitinol stents of the superficial femoral artery yielded improved morphological and clinical results compared with balloon angioplasty with optional stenting until 12 months in a randomized controlled trial. We now report 2-year data on restenosis and clinical outcomes of these patients. METHODS AND RESULTS Of 104 patients with chronic limb isch...
متن کامل